Cargando...
Albumin in Acute Stroke (ALIAS) Trials: Analysis of the combined data from Parts 1 and 2
BACKGROUND AND PURPOSE: The Albumin in Acute Stroke (ALIAS) Part 1 and 2 Trials evaluated whether 25% human serum albumin improves clinical outcomes after acute ischemic stroke above and beyond standard of care using similar protocols. The Part 1 Trial ended prematurely due to safety concerns, and t...
Guardado en:
| Publicado en: | Stroke |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2016
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4995121/ https://ncbi.nlm.nih.gov/pubmed/27462118 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.116.012825 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|